Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients
Authors
Keywords
-
Journal
Genome Medicine
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-15
DOI
10.1186/s13073-022-01101-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer patients’ understandings of genetic variants of uncertain significance in clinical care
- (2022) Yael Amano et al. Journal of Community Genetics
- Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
- (2021) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- Spectrum of splicing variants in disease genes and the ability of RNA analysis to reduce uncertainty in clinical interpretation
- (2021) Rebecca Truty et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Therapeutic Implications of Germline Testing in Patients With Advanced Cancers
- (2021) Zsofia K. Stadler et al. JOURNAL OF CLINICAL ONCOLOGY
- Paired Tumor-Normal Sequencing Provides Insights into TP53-Related Cancer Spectrum in Li-Fraumeni Patients
- (2021) Ozge Ceyhan-Birsoy et al. JNCI-Journal of the National Cancer Institute
- The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer?
- (2021) Ying L. Liu et al. Journal of the National Comprehensive Cancer Network
- Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach
- (2021) Sandrine M. Caputo et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Reanalysis of eMERGE phase III sequence variants in 10,500 participants and infrastructure to support the automated return of knowledge updates
- (2021) Hana Zouk et al. GENETICS IN MEDICINE
- The mutational constraint spectrum quantified from variation in 141,456 humans
- (2020) Konrad J. Karczewski et al. NATURE
- Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer
- (2020) Stephen E. Lincoln et al. JAMA Network Open
- Characterization and Clinical Outcomes of DNA Mismatch Repair–deficient Small Bowel Adenocarcinoma
- (2020) Alicia Latham et al. CLINICAL CANCER RESEARCH
- Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome
- (2020) N. Jewel Samadder et al. JAMA Oncology
- Patients' perspectives of variants of uncertain significance and strategies for uncertainty management
- (2019) Sukh Makhnoon et al. Journal of Genetic Counseling
- Tumour lineage shapes BRCA-mediated phenotypes
- (2019) Philip Jonsson et al. NATURE
- Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma
- (2019) Liying Zhang et al. HUMAN MUTATION
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019
- (2019) Samir Gupta et al. Journal of the National Comprehensive Cancer Network
- Inherited DNA-Repair Defects in Colorectal Cancer
- (2018) Saud H. AlDubayan et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Pathogenic Germline Variants in 10,389 Adult Cancers
- (2018) Kuan-lin Huang et al. CELL
- Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma
- (2018) Maria I. Carlo et al. JAMA Oncology
- Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer
- (2018) Alicia Latham et al. JOURNAL OF CLINICAL ONCOLOGY
- Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
- (2018) Peter D. Beitsch et al. JOURNAL OF CLINICAL ONCOLOGY
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls
- (2017) Jenna Lilyquist et al. GYNECOLOGIC ONCOLOGY
- Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing
- (2017) Diana Mandelker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rare, protein-truncating variants in ATM , CHEK2 and PALB2 , but not XRCC2 , are associated with increased breast cancer risks
- (2017) Brennan Decker et al. JOURNAL OF MEDICAL GENETICS
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017
- (2017) Samir Gupta et al. Journal of the National Comprehensive Cancer Network
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
- (2017) Fergus J. Couch et al. JAMA Oncology
- Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol
- (2016) F. Meric-Bernstam et al. ANNALS OF ONCOLOGY
- Risks of first and subsequent cancers amongTP53mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort
- (2016) Phuong L. Mai et al. CANCER
- Germline Analysis from Tumor–Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings
- (2016) Bryce A. Seifert et al. CLINICAL CANCER RESEARCH
- Ovarian cancer in Lynch syndrome; a systematic review
- (2016) J.M. Helder-Woolderink et al. EUROPEAN JOURNAL OF CANCER
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
- (2016) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer
- (2016) J. Vijai et al. Cancer Discovery
- Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors
- (2016) D. Williams Parsons et al. JAMA Oncology
- Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA
- (2016) Kasmintan A. Schrader et al. JAMA Oncology
- BRCA1andBRCA2genetic testing—pitfalls and recommendations for managing variants of uncertain clinical significance
- (2015) D. M. Eccles et al. ANNALS OF ONCOLOGY
- Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer
- (2015) Nimmi S. Kapoor et al. ANNALS OF SURGICAL ONCOLOGY
- Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification fromBRCAtesting
- (2015) C.L. Scherr et al. CLINICAL GENETICS
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
- (2015) Sue Richards et al. GENETICS IN MEDICINE
- Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
- (2015) Gaëlle Bougeard et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility
- (2015) Mark E. Robson et al. JOURNAL OF CLINICAL ONCOLOGY
- Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
- (2015) Donavan T. Cheng et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Germline RECQL mutations are associated with breast cancer susceptibility
- (2015) Cezary Cybulski et al. NATURE GENETICS
- Germline Mutations in Predisposition Genes in Pediatric Cancer
- (2015) Jinghui Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Personalized genomic analyses for cancer mutation discovery and interpretation
- (2015) Siân Jones et al. Science Translational Medicine
- Patterns and functional implications of rare germline variants across 12 cancer types
- (2015) Charles Lu et al. Nature Communications
- A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment
- (2014) Heather Hampel et al. GENETICS IN MEDICINE
- Cancer Genomics and Inherited Risk
- (2014) Zsofia K. Stadler et al. JOURNAL OF CLINICAL ONCOLOGY
- Epithelial Inflammation Resulting from an Inherited Loss-of-Function Mutation in EGFR
- (2014) Patrick Campbell et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- APC Polymorphisms and the Risk of Colorectal Neoplasia: A HuGE Review and Meta-Analysis
- (2013) Jing Liang et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling
- (2013) S. Richter et al. ANNALS OF ONCOLOGY
- Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004
- (2013) A MacCarthy et al. BRITISH JOURNAL OF CANCER
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- The CHEK2 I157T Variant and Breast Cancer Susceptibility: A Systematic Review and Meta-analysis
- (2012) Chuan Liu et al. Asian Pacific Journal of Cancer Prevention
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility
- (2011) He-ping Xiang et al. EUROPEAN JOURNAL OF CANCER
- Germline BAP1 mutations predispose to malignant mesothelioma
- (2011) Joseph R Testa et al. NATURE GENETICS
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
- (2011) T. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
- (2010) A. McKenna et al. GENOME RESEARCH
- 2009 Version of the Chompret Criteria for Li Fraumeni Syndrome
- (2009) Julie Tinat et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now